X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (853) 853
Patent (208) 208
Publication (109) 109
Book / eBook (15) 15
Book Chapter (13) 13
Conference Proceeding (10) 10
Book Review (4) 4
Web Resource (2) 2
Government Document (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (450) 450
animals (199) 199
peptides (199) 199
oncology (196) 196
chemistry (195) 195
human necessities (194) 194
hygiene (194) 194
medical or veterinary science (194) 194
metallurgy (193) 193
preparations for medical, dental, or toilet purposes (193) 193
organic chemistry (184) 184
index medicus (156) 156
immunology (155) 155
mice (133) 133
biochemistry (128) 128
melanoma - immunology (127) 127
microbiology (124) 124
immunotherapy (123) 123
beer (122) 122
enzymology (122) 122
investigating or analysing materials by determining theirchemical or physical properties (122) 122
measuring (122) 122
mutation or genetic engineering (122) 122
physics (122) 122
spirits (122) 122
testing (122) 122
vinegar (122) 122
wine (122) 122
female (115) 115
cancer (114) 114
compositions thereof (104) 104
culture media (104) 104
microorganisms or enzymes (104) 104
propagating, preserving or maintaining microorganisms (104) 104
melanoma (98) 98
article (88) 88
monoclonal-antibodies (87) 87
male (86) 86
cell line, tumor (85) 85
specific therapeutic activity of chemical compounds ormedicinal preparations (79) 79
expression (77) 77
antibodies, monoclonal - immunology (71) 71
antigens, neoplasm - immunology (67) 67
down-regulation (57) 57
antigens (56) 56
middle aged (56) 56
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (55) 55
melanoma - pathology (54) 54
neoplasms - immunology (53) 53
melanoma-specific antigens (52) 52
tumors (52) 52
aged (51) 51
antibodies, monoclonal (50) 50
cell line (50) 50
tumor cells, cultured (49) 49
t-lymphocytes - immunology (48) 48
histocompatibility antigens class i - immunology (47) 47
adult (46) 46
prognosis (45) 45
monoclonal antibodies (43) 43
melanoma - therapy (42) 42
melanoma - metabolism (41) 41
immunohistochemistry (40) 40
molecular weight (39) 39
flow cytometry (38) 38
cell biology (37) 37
hla antigens - immunology (37) 37
research (36) 36
antibody specificity (35) 35
mice, inbred balb c (35) 35
cells (33) 33
immune escape (33) 33
antibodies (32) 32
neoplasm proteins - immunology (32) 32
t-lymphocytes, cytotoxic - immunology (32) 32
antigens, neoplasm (31) 31
cancer research (31) 31
health aspects (31) 31
histocompatibility antigens class i - metabolism (31) 31
medicine, research & experimental (31) 31
antigen presentation - immunology (30) 30
cells, cultured (30) 30
t-cells (30) 30
care and treatment (29) 29
molecular sequence data (29) 29
antigen presentation (28) 28
dendritic cells (28) 28
gene expression (28) 28
gene expression regulation, neoplastic (28) 28
histocompatibility antigens (28) 28
lymphocytes (28) 28
metastatic melanoma (28) 28
neoplasms - therapy (28) 28
amino acid sequence (27) 27
melanoma - genetics (27) 27
processes using microorganisms (27) 27
aged, 80 and over (26) 26
antibodies, monoclonal - therapeutic use (26) 26
cd8-positive t-lymphocytes - immunology (26) 26
epitopes (26) 26
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1079) 1079
French (88) 88
German (46) 46
Japanese (6) 6
Spanish (6) 6
Chinese (4) 4
Danish (3) 3
Portuguese (3) 3
Finnish (1) 1
Greek (1) 1
Italian (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Cancer Letters, ISSN 0304-3835, 11/2017, Volume 409, pp. 9 - 19
Journal Article
Journal Article
Neoplasia, ISSN 1476-5586, 2014, Volume 16, Issue 1, pp. 31 - W15
Journal Article
CA: A Cancer Journal for Clinicians, ISSN 0007-9235, 09/2012, Volume 62, Issue 5, pp. 309 - 335
The immunotherapy of cancer has made significant strides in the past few years due to improved understanding of the underlying principles of tumor biology and... 
PHASE-III TRIAL | TUMOR-INFILTRATING LYMPHOCYTES | HIGH-RISK MELANOMA | ANTI-CD40 MONOCLONAL-ANTIBODY | METASTATIC MALIGNANT-MELANOMA | PULSED DENDRITIC CELLS | COLONY-STIMULATING FACTOR | ONCOLOGY | HEPATOCELLULAR-CARCINOMA PATIENTS | CD8(+) T-CELLS | RECOMBINANT INTERLEUKIN-2 THERAPY | Immunotherapy - methods | Dendritic Cells - immunology | Humans | Dendritic Cells - physiology | Antibodies, Monoclonal - therapeutic use | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Bevacizumab | Cancer Vaccines - therapeutic use | Neoplasms - therapy | Immunotherapy - trends | Angiogenesis Inhibitors - therapeutic use | Receptor, ErbB-2 - antagonists & inhibitors | Cetuximab | Yttrium Radioisotopes - therapeutic use | Gene Transfer Techniques | Histocompatibility Antigens - immunology | Antibodies, Monoclonal, Humanized - therapeutic use | Alemtuzumab | Vaccines, DNA - therapeutic use | alpha-Fetoproteins - therapeutic use | alpha-Fetoproteins - immunology | Neoplasms - immunology | Tumor Necrosis Factor Receptor Superfamily, Member 9 - antagonists & inhibitors | Receptor, Epidermal Growth Factor - antagonists & inhibitors | T-Lymphocytes - immunology | Genetic Vectors | Trastuzumab | Care and treatment | Usage | Research | Health aspects | Immunotherapy | Cancer | Immunology | Cancer therapies | Manipulation | Tumors
Journal Article